Artwork

内容由Dr Neil Love提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr Neil Love 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)

39:40
 
分享
 

Manage episode 431676612 series 1464173
内容由Dr Neil Love提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr Neil Love 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics:

  • Pathological assessment of HER2 and appropriate testing methodologies (0:00)
  • Effect of the DESTINY-Breast04 study on clinical practice (12:32)
  • Relevancy of HER2-ultralow expression and implications of the DESTINY-Breast06 study (22:53)
  • Future directions in the pathological and clinical assessment of HER2-positive breast cancer (31:06)

CME information and select publications

  continue reading

1432集单集

Artwork
icon分享
 
Manage episode 431676612 series 1464173
内容由Dr Neil Love提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr Neil Love 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics:

  • Pathological assessment of HER2 and appropriate testing methodologies (0:00)
  • Effect of the DESTINY-Breast04 study on clinical practice (12:32)
  • Relevancy of HER2-ultralow expression and implications of the DESTINY-Breast06 study (22:53)
  • Future directions in the pathological and clinical assessment of HER2-positive breast cancer (31:06)

CME information and select publications

  continue reading

1432集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南